Original Article

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Antibiotic Use among Patients Hospitalized with COVID-19 and Treated in Three Different Clinics

Oğuz Evlice and others

The clinical spectrum of COVID-19 varies, ranging from asymptomatic infection to critical illness. The most commonly used tool for the classification of disease severity is the National Institute of Health (NIH) severity scale, which has four categories: mild, moderate, severe, and critical. Patients with moderate and severe clinical courses are followed up in wards, while those with (...) Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

Factors Associated with Gram-Negative Bacteremia and Mortality in Neutropenic Patients with Hematologic Malignancies in a High-Resistance Setting

Caglayan Merve Ayaz and others

The number of patients with hematological malignancies (HMs) and those undergoing hematopoietic stem cell transplantation (HSCT) has been on rise during the last three decades. Febrile neutropenia (FN) is the most common complication in this specific patient group and requires urgent intervention. Bacteremia […] Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

Necrotizing Fasciitis: Evaluation of 85 Cases and Usage of LRINEC Score

Ebru Oruç and others

Necrotizing fasciitis (NF), one of the necrotizing soft tissue infections, is an infection that primarily involves subcutaneous adipose tissue, which consists of superficial fascia, vascular and neural structures, and involves in deep fascia and progresses with mortality. It may be difficult to differentiate (...) Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

HIV and SARS‐Cov‐2 Co-Infection: A Local Perspective

Heval Can Bilek and Aydın Deveci

In early December 2019, interstitial pneumonia of unknown origin emerged in Wuhan, the capital of China’s Hubei province. The pathogen was identified as a novel beta coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the disease caused by SARS-CoV-2 was later named (...) Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

Appropriate Use of Tocilizumab in COVID-19: Early Use is Beneficial

Lütfiye Nilsun Altunal and others

Clinically COVID-19 can be observed with mild symptoms such as fever, malaise, cough, and also severe symptoms such as acute respiratory distress syndrome (ARDS) that may require respiratory support in up to 25% of the patients . COVID-19 has a high mortality rate, in hospitalized (...) Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

Nasopharyngeal Carriage and Serotype Distribution of Streptococcus pneumoniae in Elderly: A Cross-sectional Study in Turkey

Muammer Çelik and others

Invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae is an important cause of morbidity and mortality among young children and adults 65 years and older. S. pneumoniae is one of the most important causes of serious diseases, such as pneumonia, meningitis, and bacteremia. According to 2018 surveillance data from US Centers for Disease (...) Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

West Nile Virus Seroprevalence in Manisa Province: A Population-based Study

Abdurrahman Gülmez and others

West Nile Virus (WNV) is an enveloped RNA virus with icosahedral symmetry and with a size of 45-50 nm belonging to the family Flaviviridae, genus Flavivirus (1). The virus, which was first isolated from a woman living in the West Nile region of Uganda in 1937, was noted with consecutive outbreaks in North Africa (...) Read More